Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Monoclonal antibody to CD166 and method for production thereof










Image Number 2 for United States Patent #8003762.

CD166 is a cell adhesion molecule belonging to an immunoglobulin superfamily that is expressed in an excessive amount on the tumor surface. If an monoclonal antibody specifically binding to the CD166 is obtained, it becomes possible to suppress growth of tumor cells, detect the cells, and supply a therapeutic drug thereto specifically. However, because the CD166 proteins are very similar to each other among mammals, it was not possible to obtain an antibody to human CD166, by immunizing, for example, mice with the human CD166. The antibody was prepared by immunizing mice with a purified avian CD166 protein. The antibody was found to be adsorbed on human and mouse CD166 proteins in vitro as well as in vivo and to have an action to suppress tumor growth in mice.








 
 
  Recently Added Patents
Apparatus and method for encoding/decoding signal
Solid state lighting devices with cellular arrays and associated methods of manufacturing
Calibration of quadrature imbalances using wideband signals
Semiconductor device and manufacturing method thereof
Circuit device for preventing radiation emission in portable terminal with two cameras
Modulators of cystic fibrosis transmembrane conductance regulator
Tire tread
  Randomly Featured Patents
System and method for seamlessly joining multicast session
Parameterized cells for generating dense layouts of VLSI circuits
Medical apparatus containing device, discarding device and method of use of medical apparatus
Mail box
Methods and systems for managing network connections in a software provisioning environment
Epoxy resin composition
Offline setup recording device and method and electronic apparatus using the same
Early warning mechanism for enhancing enterprise availability
Frequency generator with digitally controlled phase modulation
Bucky paper as a support membrane in retinal cell transplantation